Medical News

RSS

CMSC analyses patient self-management in Multiple Sclerosis

The Consortium of Multiple Sclerosis Centers (CMSC) released a white paper, written by a panel chaired by CMSC member Robert T. Fraser, Ph.D., of the University of Washington Rehabilitation Research and Training Center in Seattle, Washington, analyzing patient self-management in Multiple Sclerosis (MS) to develop recommendations for best practices aimed at improving patients' lives.

26 Oct 2009

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

26 Oct 2009

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Allegheny Technologies Incorporated announced that it has completed the purchase of the assets of Crucible Compaction Metals and Crucible Research for $40.95 million.

26 Oct 2009

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.

26 Oct 2009

Dysport, a new wrinkle fighter, available now in the United States

The story: Dysport(TM), a new wrinkle fighter, is now available in the United States. Dysport(TM) is a Botulinum-A enzyme like Botox Cosmetic. Dysport(TM) is positioned as the new arch-nemesis and first direct competitor of Botox Cosmetic in the United States.

26 Oct 2009

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

HealthSouth Corporation today announced that its Board of Directors has authorized the Company to amend its bylaws to adopt procedures relating to shareholder nominations for the election of directors.

26 Oct 2009

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

German based LIFEBRIDGE AG has received clearance from the U.S. Food and Drug Administration (FDA) for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide.

26 Oct 2009

Dey Pharma launches EpiPen Auto-Injector

Dey Pharma, L.P., a subsidiary of Mylan Inc., today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use.

26 Oct 2009

Third-quarter financial results announced by Roper Industries

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2009.

26 Oct 2009

American Heart Association joins international organizations to fight the global threat of stroke

During this year's observance of "World Stroke Day," Thursday, October 29, the American Heart Association and its division, the American Stroke Association, will join international organizations with a unified message about the global threat of stroke.

26 Oct 2009

Tru-flo urinary catheter valve from ProtekMed

ProtekMed has launched the Tru-flo(TM) urinary catheter valve, an innovative and economical alternative to the standard tube and bag system prescribed by most urologists today.

26 Oct 2009

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.

26 Oct 2009

First physician affiliated with Renaissance Health Systems goes live with PWeR

The Quantum Group, Inc. announced today that the first physician affiliated with Quantum subsidiary Renaissance Health Systems has “gone live” with PWeR™ (Personal Wellness electronic Record™), the one patient, one record™ electronic medical record platform offered by Quantum Innovations, Inc.

26 Oct 2009

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

In a recent study of workers’ compensation injury cases, Electromyography (EMG) and Nerve Conduction Studies (NCSs), which were performed by physicians who were not evaluated and pre-determined to meet a certain level of quality, were discovered to be highly unreliable.

26 Oct 2009

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child’s stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.

26 Oct 2009

Cel Sci completes its production facility for Multikine Phase III clinical trial

BioMedReports, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, was given an exclusive tour of CEL-SCI Corporation's, new, state-of-the-art manufacturing facility near Baltimore, MD where the potentially ground breaking cancer immunotherapy treatment, Multikine, will be manufactured to support an upcoming Phase III clinical trial.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Medical News

CMSC analyses patient self-management in Multiple Sclerosis

Results from Phase I dose-escalation study of AT-101 announced

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Dysport, a new wrinkle fighter, available now in the United States

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

Dey Pharma launches EpiPen Auto-Injector

Third-quarter financial results announced by Roper Industries

American Heart Association joins international organizations to fight the global threat of stroke

Tru-flo urinary catheter valve from ProtekMed

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

First physician affiliated with Renaissance Health Systems goes live with PWeR

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Cel Sci completes its production facility for Multikine Phase III clinical trial

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Overview of Compugen’s DAC Blockers Platform presented at Fifth Peptide Engineering Meeting

Winners of the EDCTP Award For Outstanding African Scientist

Preliminary results for fiscal 2010 first quarter released by Rural/Metro

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News